{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:50:42Z","timestamp":1792144242302,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2022D01E81"],"award-info":[{"award-number":["2022D01E81"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpet.2026.105032","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:59:11Z","timestamp":1790006351000},"page":"105032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interleukin-37 overexpression enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells in atopic dermatitis by activating autophagy and improving skin barrier dysfunction"],"prefix":"10.1016","volume":"393","author":[{"given":"Wenjing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2026.105032_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1361005","article-title":"Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches","volume":"15","author":"Afshari","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jpet.2026.105032_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1390","article-title":"Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics","volume":"11","author":"Kwatra","year":"2022","journal-title":"Clin Transl Immunol"},{"issue":"9","key":"10.1016\/j.jpet.2026.105032_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamadermatol.2024.2192","article-title":"Systemic immunomodulatory treatments for atopic dermatitis: Living systematic review and network meta-analysis update","volume":"160","author":"Drucker","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105032_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2220444","article-title":"Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis","volume":"34","author":"Han","year":"2023","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.jpet.2026.105032_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jcb.30365","article-title":"Recent advances in mesenchymal stem cell therapy for atopic dermatitis","volume":"124","author":"Najera","year":"2023","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.jpet.2026.105032_bib6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3390\/ijms21041306","article-title":"Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing","volume":"21","author":"Mazini","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.jpet.2026.105032_bib7","article-title":"An update on adipose-derived stem cells for regenerative medicine: Where challenge meets opportunity","volume":"10","author":"Qin","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"10.1016\/j.jpet.2026.105032_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1042\/BSR20190433","article-title":"Overexpressed vascular endothelial growth factor in adipose-derived stem cells attenuates fibroblasts and skin injuries by ultraviolet radiation","volume":"39","author":"Xie","year":"2019","journal-title":"Biosci Rep"},{"issue":"9","key":"10.1016\/j.jpet.2026.105032_bib9","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/jdv.19239","article-title":"Interleukin-37 inhibits desmoglein-3 endocytosis and keratinocyte dissociation via upregulation of Caveolin-1 and inhibition of the STAT3 pathway","volume":"37","author":"Liang","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"19","key":"10.1016\/j.jpet.2026.105032_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/ijms241914633","article-title":"Regulatory mechanism of the IL-33-IL-37 axis via aryl hydrocarbon receptor in atopic dermatitis and psoriasis","volume":"24","author":"Tsuji","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.105032_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fimmu.2020.00752","article-title":"IL-37 ameliorating allergic inflammation in atopic dermatitis through regulating microbiota and AMPK-mTOR signaling pathway-modulated autophagy mechanism","volume":"11","author":"Hou","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jpet.2026.105032_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/acel.12655","article-title":"Autophagy in stem cell aging","volume":"16","author":"Revuelta","year":"2017","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.jpet.2026.105032_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1681\/ASN.2019050545","article-title":"Additive therapeutic effects of mesenchymal stem cells and IL-37 for systemic lupus erythematosus","volume":"31","author":"Xu","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpet.2026.105032_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.749192","article-title":"Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.105032_bib15","article-title":"Mesenchymal stem cell therapy: Hope for patients with systemic lupus erythematosus","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.105032_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156699","article-title":"The role of mesenchymal stem cells in the treatment and pathogenesis of psoriasis","volume":"182","author":"Chen","year":"2024","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.jpet.2026.105032_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000501071","article-title":"In vitro engineering of a skin substitute based on adipose-derived stem cells","volume":"207","author":"Paganelli","year":"2019","journal-title":"Cells Tissues Organs"},{"issue":"21","key":"10.1016\/j.jpet.2026.105032_bib18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/vr.104867","article-title":"Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: Clinical efficacy and safety","volume":"183","author":"Villatoro","year":"2018","journal-title":"Vet Rec"},{"issue":"3","key":"10.1016\/j.jpet.2026.105032_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/exd.13895","article-title":"Adipose-derived stem cells attenuate atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"28","author":"Park","year":"2019","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105032_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s11658-022-00366-0","article-title":"Aging of mesenchymal stem cell: Machinery, markers, and strategies of fighting","volume":"27","author":"Al-Azab","year":"2022","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"10.1016\/j.jpet.2026.105032_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112780","article-title":"Extracellular IL-37 promotes osteogenic and odontogenic differentiation of human dental pulp stem cells via autophagy","volume":"407","author":"Li","year":"2021","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jpet.2026.105032_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101963","article-title":"LRRc17 controls BMSC senescence via mitophagy and inhibits the therapeutic effect of BMSCs on ovariectomy-induced bone loss","volume":"43","author":"Liu","year":"2021","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105032_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292050","article-title":"Adipose tissue-derived exosomes alleviate particulate matter-induced inflammatory response and skin barrier damage in atopic dermatitis-like triple-cell model","volume":"19","author":"Roh","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jpet.2026.105032_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jdermsci.2021.04.007","article-title":"Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents","volume":"102","author":"Luger","year":"2021","journal-title":"J Dermatol Sci"},{"issue":"5","key":"10.1016\/j.jpet.2026.105032_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000543902","article-title":"Batryticatus bombyx improves atopic dermatitis in NC\/Nga mice and impacts inflammation and recovery of skin barrier via STAT1\/P38\/NF-\u03baB downregulation and HO-1\/Nrf2 Activation in HaCaT Keratinocytes","volume":"110","author":"Park","year":"2025","journal-title":"Pharmacology"},{"issue":"5","key":"10.1016\/j.jpet.2026.105032_bib26","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler CFt","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105032_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12272-021-01305-x","article-title":"Skin barrier dysfunction and filaggrin","volume":"44","author":"Kim","year":"2021","journal-title":"Arch Pharm Res"},{"issue":"15","key":"10.1016\/j.jpet.2026.105032_bib28","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.3390\/ijms21155382","article-title":"Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic implications in atopic dermatitis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jpet.2026.105032_bib29","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jid.2024.08.038","article-title":"Trehalose prevents IL-4\/IL-13-induced skin barrier impairment by suppressing IL-33 expression and increasing NRF2 activation in human keratinocytes in vitro","volume":"145","author":"Dai","year":"2025","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jpet.2026.105032_bib30","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jaci.2012.01.068","article-title":"Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice","volume":"129","author":"Kawasaki","year":"2012","journal-title":"J Allergy Clin Immunol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:41:51Z","timestamp":1792143711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526012322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022356526012322"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105032","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-37 overexpression enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells in atopic dermatitis by activating autophagy and improving skin barrier dysfunction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"105032"}}